Carregant...
Chemoresponse Assay in Head and Neck Cancer Patients: A Three-Year Follow Up
INTRODUCTION: The majority of patients with advanced head and neck cancer receiving chemotherapy show partial response or frank resistance. Therefore, assessing the individuals’ tumour reactivity to the eligible chemotherapeutic compounds carries the potential of personalizing the patient treatment...
Guardat en:
| Publicat a: | J Clin Diagn Res |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
JCDR Research and Publications (P) Limited
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5483792/ https://ncbi.nlm.nih.gov/pubmed/28658890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2017/24802.9816 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|